Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR,branches of the ESC. Endorsed by APHRS,HRS,and SOLAECE

Kim JH Malhotra R Chiampas G d’Hemecourt P Troyanos C Cianca J , et al.. Cardiac arrest during long-distance running races. N Engl J Med 2012; 366: 130–40.

Harmon KG Asif IM Maleszewski JJ Owens DS Prutkin JM Salerno JC , et al.. Incidence, etiology, and comparative frequency of sudden cardiac death in NCAA athletes: a decade in review. Circulation 2015; 132: 10–19.

Corrado D Basso C Pavei A Michieli P Schiavon M Thiene G . Trends in sudden cardiovascular death in young competitive athletes after implementation of a pre-participation screening program. JAMA 2006; 296: 1593–601.

Marijon E Tafflet M Celermajer DS Dumas F Perier MC Mustafic H , et al.. Sports-related sudden death in the general population. Circulation 2011; 124: 672–81.

Corrado D Basso C Rizzoli G Schiavon M Thiene G . Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003; 42: 1959–63.

Dunn TP Pickham D Aggarwal S Saini D Kumar N Wheeler MT , et al.. Limitations of current AHA guidelines and proposal of new guidelines for the pre-participation examination of athletes. Clin J Sport Med 2015; 25: 472–7.

Pelliccia A Fagard R Bjornstad HH Anastassakis A Arbustini E Assanelli D , et al.. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005; 26: 1422–45.

Borjesson M Urhausen A Kouidi E Dugmore D Sharma S Halle M , et al.. Cardiovascular evaluation of middle-aged/senior individuals engaged in leisure-time sport activities: position stand from the sections of exercise physiology and sports cardiology of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil 2011; 18: 446–58.

Elliott PM Anastasakis A Borger MA Borggrefe M Cecchi F Charron P , et al.. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733–79.

Priori SG Blomstrom-Lundqvist C Mazzanti A Blom N Borggrefe M Camm J , et al.. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace 2015; 17: 1601–87.

Priori SG Wilde AA Horie M Cho Y Behr ER Berul C , et al.. Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace 2013; 15: 1389–406.

Pelliccia A Corrado D Bjornstad HH Panhuyzen-Goedkoop N Urhausen A Carre F , et al.. Recommendations for participation in competitive sport and leisuretime physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur J Cardiovasc Prev Rehabil 2006; 13: 876–85.

Perk J De Backer G Gohlke H Graham I Reiner Z Verschuren M , et al.. The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012; 33: 1635–701.

Harmon KG Drezner JA Wilson MG Sharma S . Incidence of sudden cardiac death in athletes: a state-of-the-art review. Heart 2014; 100: 1227–34.

Toresdahl BG Rao AL Harmon KG Drezner JA . Incidence of sudden cardiac arrest in high school student athletes on school campus. Heart Rhythm 2014; 11: 1190–4.

Risgaard B Winkel BG Jabbari R Glinge C Ingemann-Hansen O Thomsen JL , et al.. Sports-related sudden cardiac death in a competitive and a noncompetitive athlete population aged 12 to 49 years: data from an unselected nationwide study in Denmark. Heart Rhythm 2014; 11: 1673–81.

Maron BJ Haas TS Murphy CJ Ahluwalia A Rutten-Ramos S . Incidence and causes of sudden death in U.S. college athletes. J Am Coll Cardiol 2014; 63: 1636–43.

Corrado D Thiene G Nava A Rossi L Pennelli N . Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. Am J Med 1990; 89: 588–96.

Maron BJ Doerer JJ Haas TS Tierney DM Mueller FO . Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation 2009; 119: 1085–92.

Eckart RE Shry EA Burke AP McNear JA Appel DA Castillo-Rojas LM , et al.. Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. J Am Coll Cardiol 2011; 58: 1254–61.

Holst AG Winkel BG Theilade J Kristensen IB Thomsen JL Ottesen GL , et al.. Incidence and etiology of sports-related sudden cardiac death in Denmark—implications for pre-participation screening. Heart Rhythm 2010; 7: 1365–71.

Solberg EE Borjesson M Sharma S Papadakis M Wilhelm M Drezner JA , et al.. Sudden cardiac arrest in sports—need for uniform registration: A Position Paper from the Sport Cardiology Section of the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Prev Cardiol 2016; 23: 657–67.

Maron BJ Shirani J Poliac L Mathenge R Roberts WC Mueller FO . Sudden death in young competitive athletes: clinical, demographic, and pathological profiles. JAMA 1996; 276: 199–204.

Suarez-Mier MP Aguilera B . Causes of sudden death during sports activities in Spain. Rev Esp Cardiol 2002; 55: 347–58.

Watkins H Thierfelder L Hwang DS McKenna W Seidman JG Seidman CE . Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. J Clin Invest 1992; 90: 1666–71.

Semsarian C Ingles J Maron MS Maron BJ . New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 2015; 65: 1249–54.

Maron BJ Niimura H Casey SA Soper MK Wright GB Seidman JG , et al.. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol 2001; 38: 315–21.

O’Mahony C Jichi F Pavlou M Monserrat L Anastasakis A Rapezzi C , et al.. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J 2014; 35: 2010–20.

Maron BJ Pelliccia A . The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation 2006; 114: 1633–44.

Caselli S Maron MS Urbano-Moral JA Pandian NG Maron BJ Pelliccia A . Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy. Am J Cardiol 2014; 114: 1383–9.

Sheikh N Papadakis M Schnell F Panoulas V Malhotra A Wilson M , et al.. Clinical profile of athletes with hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 2015; 8: e003454–e003454.

Ryan MP Cleland JG French JA Joshi J Choudhury L Chojnowska L , et al.. The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy. Am J Cardiol 1995; 76: 689–94.

Charron P Dubourg O Desnos M Bouhour JB Isnard R Hagege A , et al.. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children. Eur Heart J 1998; 19: 1377–82.

Pelliccia A Maron BJ Culasso F Di Paolo FM Spataro A Biffi A , et al.. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation 2000; 102: 278–84.

Papadakis M Carre F Kervio G Rawlins J Panoulas VF Chandra N , et al.. The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin. Eur Heart J 2011; 32: 2304–13.

Sheikh N Papadakis M Ghani S Zaidi A Gati S Adami PE , et al.. Comparison of electrocardiographic criteria for the detection of cardiac abnormalities in elite black and white athletes. Circulation 2014; 129: 1637–49.

Corrado D Basso C Thiene G McKenna WJ Davies MJ Fontaliran F , et al.. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 1997; 30: 1512–20.

Corrado D Basso C Thiene G . Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart 2000; 83: 588–95.

Corrado D Thiene G . Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. Circulation 2006; 113: 1634–7.

Corrado D Basso C Pilichou K Thiene G . Molecular biologyand clinical management of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart 2011; 97: 530–9.

Migliore F Zorzi A Silvano M Bevilacqua M Leoni L Marra MP , et al.. Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circ Arrhythm Electrophysiol 2013; 6: 167–76.

James CA Bhonsale A Tichnell C Murray B Russell SD Tandri H , et al.. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol 2013; 62: 1290–7.

Saberniak J Hasselberg NE Borgquist R Platonov PG Sarvari SI Smith HJ , et al.. Vigorous physical activity impairs myocardial function in patients with arrhythmo-genic right ventricular cardiomyopathy and in mutation positive family members. Eur J Heart Fail 2014; 16: 1337–44.

Ruwald AC Marcus F Estes NA 3rd Link M McNitt S Polonsky B , et al.. Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J 2015; 36: 1735–43.

McKenna WJ Thiene G Nava A Fontaliran F Blomstrom-Lundqvist C Fontaine G , et al.. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994; 71: 215–8.

Marcus FI McKenna WJ Sherrill D Basso C Bauce B Bluemke DA , et al.. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J 2010; 31: 806–14.

Corrado D Basso C Thiene G . Arrhythmogenic right ventricular cardiomyopathy: an update. Heart 2009; 95: 766–73.

Corrado D Schmied C Basso C Borjesson M Schiavon M Pelliccia A , et al.. Risk of sports: do we need a pre-participation screening for competitive and leisure athletes? Eur Heart J 2011; 32: 934–44.

Platonov PG Calkins H Hauer RN Corrado D Svendsen JH Wichter T , et al.. High interobserver variability in the assessment of epsilon waves: implications for diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm 2016; 13: 208–16.

Marra MP Leoni L Bauce B Corbetti F Zorzi A Migliore F , et al.. Imaging study of ventricular scar in arrhythmogenic right ventricular cardiomyopathy: comparison of 3D standard electroanatomical voltage mapping and contrast-enhanced cardiac magnetic resonance. Circ Arrhythm Electrophysiol 2012; 5: 91–100.

Gomes J Finlay M Ahmed AK Ciaccio EJ Asimaki A Saffitz JE , et al.. Electrophysio-logical abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathydue to mutations in desmoplakin-A combined murine and human study. Eur Heart J 2012; 33: 1942–53.

Te Rijdt WP Jongbloed JD de Boer RA Thiene G Basso C van den Berg MP , et al.. Clinical utility gene card for: arrhythmogenic right ventricular cardiomyopathy (ARVC). Eur J Hum Genet 2014; 22. doi:10.1038/ejhg.2013.124.

Angelini P . Coronary artery anomalies: an entity in search of an identity. Circulation 2007; 115: 1296–305.

Basso C Maron BJ Corrado D Thiene G . Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol 2000; 35: 1493–501.

Wyman RA Chiu RY Rahko PS . The 5-minute screening echocardiogram for athletes. J Am Soc Echocardiogr 2008; 21: 786–8.

Hiss RG Lamb LE . Electrocardiographic findings in 122,043 individuals. Circulation 1962; 25: 947–61.

Aras D Tufekcioglu O Ergun K Ozeke O Yildiz A Topaloglu S , et al.. Clinical features of isolated ventricular noncompaction in adults long-term clinical course, echocardiographic properties, and predictors of left ventricular failure. J Card Fail 2006; 12: 726–33.

Towbin JA Lorts A Jefferies JL . Left ventricular non-compaction cardiomyopathy. Lancet 2015; 386: 813–25.

Brescia ST Rossano JW Pignatelli R Jefferies JL Price JF Decker JA , et al.. Mortality and sudden death in pediatric left ventricular noncompaction in a tertiary referral center. Circulation 2013; 127: 2202–8.

Caselli S Attenhofer Jost CH Jenni R Pelliccia A . Left ventricular noncompaction diagnosis and management relevant to pre-participation screening of athletes. Am J Cardiol 2015; 116: 801–8.

Gati S Chandra N Bennett RL Reed M Kervio G Panoulas VF , et al.. Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes? Heart 2013; 99: 401–8.

Pinto YM Elliott PM Arbustini E Adler Y Anastasakis A Bohm M , et al.. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J 2016; 37: 1850–8.

Marijon E Uy-Evanado A Reinier K Teodorescu C Narayanan K Jouven X , et al.. Sudden cardiac arrest during sports activity in middle age. Circulation 2015; 131: 1384–91.

Pelliccia A Culasso F Di Paolo FM Maron BJ . Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med 1999; 130: 23–31.

Siu SC Silversides CK . Bicuspid aortic valve disease. J Am Coll Cardiol 2010; 55: 2789–00.

Lieve KV Wilde AA . Inherited ion channel diseases: a brief review. Europace 2015; 17(Suppl 2): ii1–6.

Schwartz PJ Stramba-Badiale M Crotti L Pedrazzini M Besana A Bosi G , et al.. Prevalence of the congenital long-QT syndrome. Circulation 2009; 120: 1761–7.

Nakano Y Shimizu W . Genetics of long-QT syndrome. J Hum Genet 2016; 61: 51–5.

Ackerman MJ Priori SG Willems S Berul C Brugada R Calkins H , et al.. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. Europace 2011; 13: 1077–109.

Fukuyama M Wang Q Kato K Ohno S Ding WG Toyoda F , et al.. Long QT syndrome type 8: novel CACNA1C mutations causing QT prolongation and variant phenotypes. Europace 2014; 16: 1828–37.

Nguyen HL Pieper GH Wilders R . Andersen-Tawil syndrome: clinical and molecular aspects. Int J Cardiol 2013; 170: 1–16.

Splawski I Timothy KW Sharpe LM Decher N Kumar P Bloise R , et al.. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004; 119: 19–31.

Schwartz PJ Priori SG Spazzolini C Moss AJ Vincent GM Napolitano C , et al.. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001; 103: 89–95.

Schwartz PJ Moss AJ Vincent GM Crampton RS . Diagnostic criteria for the long QT syndrome. An update. Circulation 1993; 88: 782–4.

Vincent GM Jaiswal D Timothy KW . Effects of exercise on heart rate, QT, QTc and QT/QS2 in the Romano-Ward inherited long QT syndrome. Am J Cardiol 1991; 68: 498–503.

Swan H Viitasalo M Piippo K Laitinen P Kontula K Toivonen L . Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQTl and HERG potassium channel defects. J Am Coll Cardiol 1999; 34: 823–9.

Horner JM Horner MM Ackerman MJ . The diagnostic utility of recovery phase QTc during treadmill exercise stress testing in the evaluation of long QT syndrome. Heart Rhythm 2011; 8: 1698–704.

Schwartz PJ Crotti L . QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation 2011; 124: 2181–4.

Sy RW van der Werf C Chattha IS Chockalingam P Adler A Healey JS , et al.. Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands. Circulation 2011; 124: 2187–94.

Viskin S Postema PG Bhuiyan ZA Rosso R Kalman JM Vohra JK , et al.. The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. J Am Coll Cardiol 2010; 55: 1955–61.

Adler A van der Werf C Postema PG Rosso R Bhuiyan ZA Kalman JM , et al.. The phenomenon of ‘QT stunning’: the abnormal QT prolongation provoked by standing persists even as the heart rate returns to normal in patients with long QT syndrome. Heart Rhythm 2012; 9: 901–8.

Stramba-Badiale M Priori SG Napolitano C Locati EH Vinolas X Haverkamp W , et al.. Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep? Ital Heart J 2000; 1: 323–8.

Priori SG Schwartz PJ Napolitano C Bloise R Ronchetti E Grillo M , et al.. Risk stratification in the long-QT syndrome. N Engl J Med 2003; 348: 1866–74.

Guerrier K Kwiatkowski D Czosek RJ Spar DS Anderson JB Knilans TK . Short QT interval prevalence and clinical outcomes in a pediatric population. Circ Arrhythm Electrophysiol 2015; 8: 1460–4.

Anttonen O Junttila MJ Rissanen H Reunanen A Viitasalo M Huikuri HV . Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population. Circulation 2007; 116: 714–20.

Dhutia H Malhotra A Parpia S Gabus V Finocchiaro G Mellor G , et al.. The prevalence and significance of a short QT interval in 18 825 low-risk individuals including athletes. Br J Sports Med 2016; 50: 124–9.

Priori SG Napolitano C Memmi M Colombi B Drago F Gasparini M , et al.. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002; 106: 69–74.

Marjamaa A Hiippala A Arrhenius B Lahtinen AM Kontula K Toivonen L , et al.. Intravenous epinephrine infusion test in diagnosis of catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol 2012; 23: 194–9.

van der Werf C Zwinderman AH Wilde AA . Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments. Europace 2012; 14: 175–83.

Brugada P Brugada J . Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992; 20: 1391–6.

Catalano O Antonaci S Moro G Mussida M Frascaroli M Baldi M , et al.. Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities. Eur Heart J 2009; 30: 2241–8.

Schulze-Bahr E Eckardt L Breithardt G Seidl K Wichter T Wolpert C , et al.. Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease. Hum Mutat 2003; 21: 651–2.

Rudic B Schimpf R Veltmann C Doesch C Tulumen E Schoenberg SO , et al.. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters. Europace 2015. In press. doi:10.1093/europace/euv300.

Mizusawa Y Wilde AA . Brugada syndrome. Circ Arrhythm Electrophysiol 2012; 5: 606–16.

Amin AS de Groot EA Ruijter JM Wilde AA Tan HL . Exercise-induced ECG changes in Brugada syndrome. Circ Arrhythm Electrophysiol 2009; 2: 531–9.

Makimoto H Nakagawa E Takaki H Yamada Y Okamura H Noda T , et al.. Augmented ST-segment elevation during recovery from exercise predicts cardiac events in patients with Brugada syndrome. J Am Coll Cardiol 2010; 56: 1576–84.

Thompson PD Franklin BA Balady GJ Blair SN Corrado D Estes NA III , et al.. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation 2007; 115: 2358–68.

Giri S Thompson PD Kiernan FJ Clive J Fram DB Mitchel JF , et al.. Clinical and angiographic characteristics of exertion-related acute myocardial infarction. JAMA 1999; 282: 1731–6.

Fletcher GF Ades PA Kligfield P Arena R Balady GJ Bittner VA , et al.. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation 2013; 128: 873–934.

Guerri-Guttenberg RA Grana DR Ambrosio G Milei J . Chagas cardiomyopathy: Europe is not spared!. Eur Heart J 2008; 29: 2587–91.

Rassi A Jr Rassi A Marin-Neto JA . Chagas disease. Lancet 2010; 375: 1388–402.

Dias JC . The indeterminate form of human chronic Chagas’ disease A clinical epidemiological review. Rev Soc Bras Med Trop 1989; 22: 147–56.

Nunes MC Dones W Morillo CA Encina JJ Ribeiro AL . Council on Chagas Disease of the Interamerican Society of Cardiology Chagas disease: an overview of clinical and epidemiological aspects. J Am Coll Cardiol 2013; 62: 767–76.

Sternick EB Martinelli M Sampaio R Gerken LM Teixeira RA Scarpelli R , et al.. Sudden cardiac death in patients with chagas heart disease and preserved left ventricular function. J Cardiovasc Electrophysiol 2006; 17: 113–6.

de Paola AA Gomes JA Terzian AB Miyamoto MH Martinez Fo EE . Ventricular tachycardia during exercise testing as a predictor of sudden death in patients with chronic chagasic cardiomyopathy and ventricular arrhythmias. Br Heart J 1995; 74: 293–5.

Martinelli Filho M Sosa E Nishioka S Scanavacca M Bellotti G Pileggi F . Clinical and electrophysiologic features of syncope in chronic chagasic heart disease. J Cardiovasc Electrophysiol 1994; 5: 563–70.

Shivkumar K Boyle NG Scanavacca M Sosa E Epicardial ablation of ventricular tachycardia in Chagas heart disease. In: Shivkumar K Boyle NG (eds). Cardiac Electrophysiology Clinics: Epicardial Interventions in Electrophysiology, Philadelphia: Saunders, 2010, pp. 55–67.

Matos LD Azevedo LF Brum PC Sosa EA Martinelli M Negrao CE . Longdistance runner with dilated cardiomyopathy and excellent performance. Arq Bras Cardiol 2011; 96: e3–6.

Cruz FM Sanz-Rosa D Roche-Molina M Garcia-Prieto J Garcia-Ruiz JM Pizarro G , et al.. Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2. J Am Coll Cardiol 2015; 65: 1438–50.

Kirchhof P Fabritz L Zwiener M Witt H Schafers M Zellerhoff S , et al.. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation 2006; 114: 1799–806.

Konhilas JP Watson PA Maass A Boucek DM Horn T Stauffer BL , et al.. Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy. Circ Res 2006; 98: 540–8.

Heidbuchel H Hoogsteen J Fagard R Vanhees L Ector H Willems R , et al.. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. Eur Heart J 2003; 24: 1473–80.

La Gerche A Robberecht C Kuiperi C Nuyens D Willems R de Ravel T , et al.. Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin. Heart 2010; 96: 1268–74.

Benito B Gay-Jordi G Serrano-Mollar A Guasch E Shi Y Tardif JC , et al.. Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation 2011; 123: 13–22.

Sawant AC Bhonsale A Te Riele AS Tichnell C Murray B Russell SD , et al.. Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients without desmosomal mutations. J Am Heart Assoc 2014; 3: e001471–e001471.

La Gerche A Heidbuchel H . Can intensive exercise harm the heart? You can get too much of a good thing. Circulation 2014; 130: 992–1002.

Heidbuchel H Prior DL La Gerche A . Ventricular arrhythmias associated with long-term endurance sports: what is the evidence? Br J Sports Med 2012; 46(Suppl 1): i44–50.

Abergel E Chatellier G Hagege AA Oblak A Linhart A Ducardonnet A , et al.. Serial left ventricular adaptations in world-class professional cyclists: implications for disease screening and follow-up. J Am Coll Cardiol 2004; 44: 144–9.

Kiel RJ Smith FE Chason J Khatib R Reyes MP . Coxsackievirus B3 myocarditis in C3H/HeJ mice: description of an inbred model and the effect of exercise on virulence. Eur J Epidemiol 1989; 5: 348–50.

Schnell F Claessen G La Gerche A Bogaert J Lentz PA Claus P , et al.. Subepicardial delayed gadolinium enhancement in asymptomatic athletes: let sleeping dogs lie? Br J Sports Med 2016; 50: 111–7.

Corrado D Basso C Schiavon M Thiene G . Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998; 339: 364–9.

Harmon KG Zigman M Drezner JA . The effectiveness of screening history, physical exam, and ECG to detect potentially lethal cardiac disorders in athletes: a systematic review/meta-analysis. J Electrocardiol 2015; 48: 329–38.

Brosnan M La Gerche A Kalman J Lo W Fallon K Maclsaac A , et al.. Comparison of frequency of significant electrocardiographic abnormalities in endurance versus nonendurance athletes. Am J Cardiol 2014; 113: 1567–73.

Senturk T Xu H Puppala K Krishnan B Sakaguchi S Chen LY , et al.. Cardiac pauses in competitive athletes: a systematic review examining the basis of current practice recommendations. Europace 2015. In press. doi:10.1093/europace/euv373.

Brosnan M La Gerche A Kalman J Lo W Fallon K Maclsaac A , et al.. The Seattle Criteria increase the specificity of preparticipation ECG screening among elite athletes. Br J Sports Med 2014; 48: 1144–50.

Rowin EJ Maron BJ Appelbaum E Link MS Gibson CM Lesser JR , et al.. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy. Am J Cardiol 2012; 110: 1027–32.

Drezner JA Fudge J Harmon KG Berger S Campbell RM Vetter VL . Warning symptoms and family history in children and young adults with sudden cardiac arrest. J Am Board Fam Med 2012; 25: 408–15.

Maron BJ Friedman RA Kligfield P Levine BD Viskin S Chaitman BR , et al.. Assessment of the 12-lead ECG as a screening test for detection of cardiovascular disease in healthy general populations of young people (12–25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology. Circulation 2014; 130: 1303–34.

Corrado D Pelliccia A Heidbuchel H Sharma S Link M Basso C , et al.. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J 2010; 31: 243–59.

Drezner JA Ackerman MJ Anderson J Ashley E Asplund CA Baggish AL , et al.. Electrocardiographic interpretation in athletes: the ‘Seattle Criteria’. Br J Sports Med 2013; 47: 122–4.

Pickham D Zarafshar S Sani D Kumar N Froelicher V . Comparison of three ECG criteria for athlete pre-participation screening. J Electrocardiol 2014; 47: 769–74.

Berge HM Gjesdal K Andersen TE Solberg EE Steine K . Prevalence of abnormal ECGs in male soccer players decreases with the Seattle criteria, but is still high. Scand J Med Sci Sports 2015; 25: 501–8.

Corrado D Calore C Zorzi A Migliore F . Improving the interpretation of the athlete’s electrocardiogram. Eur Heart J 2013; 34: 3606–9.

Viskin S Rosovski U Sands AJ Chen E Kistler PM Kalman JM , et al.. Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one. Heart Rhythm 2005; 2: 569–74.

Berte B Duytschaever M Elices J Kataria V Timmers L Van Heuverswyn F , et al.. Variability in interpretation of the electrocardiogram in young athletes: an unrecognized obstacle for electrocardiogram-based screening protocols. Europace 2015; 17: 1435–40.

Magalski A Maron BJ Main ML McCoy M Florez A Reid KJ , et al.. Relation of race to electrocardiographic patterns in elite American football players. J Am Coll Cardiol 2008; 51: 2250–5.

Glover DW Glover DW Maron BJ . Evolution in the process of screening United States high school student-athletes for cardiovascular disease. Am J Cardiol 2007; 100: 1709–12.

Heidbuchel H Papadakis M Panhuyzen-Goedkoop N Carre F Dugmore D Mellwig KP , et al.. Position paper: proposal for a core curriculum for a European Sports Cardiology qualification. Eur J Prev Cardiol 2013; 20: 889–903.

Papadakis M Chandra N Sharma S . Controversies relating to preparticipation cardiovascular screening in young athletes: time for a realistic solution? Br J Sports Med 2011; 45: 165–6.

Solberg EE Bjornstad TH Andersen TE Ekeberg O . Cardiovascular preparticipation screening does not distress professional football players. Eur J Prev Cardiol 2012; 19: 571–7.

Asif IM Johnson S Schmieg J Smith T Rao AL Harmon KG , et al.. The psychological impact of cardiovascular screening: the athlete’s perspective. Br J Sports Med 2014; 48: 1162–6.

Sharma S Estes NA III Vetter VL Corrado D . Clinical decisions. Cardiac screening before participation in sports. N Engl J Med 2013; 369: 2049–53.

Tasaki H Hamasaki Y Ichimaru T . Mass screening for heart disease of school children in Saga city: 7-year follow up study. Jpn Circ J 1987; 51: 1415–20.

Vetter VL Dugan N Guo R Mercer-Rosa L Gleason M Cohen M , et al.. A pilot study of the feasibility of heart screening for sudden cardiac arrest in healthy children. Am Heart J 2011; 161: 1000–1006.e3.

Lahav D Leshno M Brezis M . Is an exercise tolerance test indicated before beginning regular exercise? A decision analysis. J Gen Intern Med 2009; 24: 934–8.

Gianrossi R Detrano R Mulvihill D Lehmann K Dubach P Colombo A , et al.. Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation 1989; 80: 87–98.

Schnell F Riding N O’Hanlon R Axel Lentz P Donal E Kervio G , et al.. Recognition and significance of pathological T-wave inversions in athletes. Circulation 2015; 131: 165–73.

Feinstein RA Colvin E Kimoh M . Echocardiographic screening as part of a preparticipation examination. Clin J Sport Med 1993; 3: 149–52.

Weidenbener EJ Krauss MD Waller BF Taliercio CP . Incorporation of screening echocardiography in the preparticipation exam. Clin J Sport Med 1995; 5: 86–9.

Anderson JB Grenier M Edwards NM Madsen NL Czosek RJ Spar DS , et al.. Usefulness of combined history, physical examination, electrocardiogram, and limited echocardiogram in screening adolescent athletes for risk for sudden cardiac death. AmJCardiol 2014; 114: 1763–7.

Riding NR Sharma S Salah O Khalil N Carre F George KP , et al.. Systematic echocardiography is not efficacious when screening an ethnically diverse cohort of athletes in West Asia. Eur J Prev Cardiol 2015; 22: 263–70.

Lewis JF Maron BJ Diggs JA Spencer JE Mehrotra PP Curry CL . Preparticipation echocardiographic screening for cardiovascular disease in a large, predominantly black population of collegiate athletes. Am J Cardiol 1989; 64: 1029–33.

Zaidi A Ghani S Sharma R Oxborough D Panoulas VF Sheikh N , et al.. Physiological right ventricular adaptation in elite athletes of African and Afro-Caribbean origin. Circulation 2013; 127: 1783–92.

Jellis C Martin J Narula J Marwick TH . Assessment of nonischemic myocardial fibrosis. J Am Coll Cardiol 2010; 56: 89–97.

La Gerche A Claessen G Dymarkowski S Voigt JU De Buck F Vanhees L , et al.. Exercise-induced right ventricular dysfunction is associated with ventricular arrhythmias in endurance athletes. Eur Heart J 2015; 36: 1998–2010.

La Gerche A Burns AT Mooney DJ Inder WJ Taylor AJ Bogaert J , et al.. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J 2012; 33: 998–1006.

Wilson M O’Hanlon R Prasad S Deighan A Macmillan P Oxborough D , et al.. Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. J Appl Physiol 2011; 110: 1622–6.

Davis JA Cecchin F Jones TK Portman MA . Major coronary artery anomalies in a pediatric population: incidence and clinical importance. J Am Coll Cardiol 2001; 37: 593–7.

Albert CM Mittleman MA Chae CU Lee IM Hennekens CH Manson JE . Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 2000; 343: 1355–61.

Yeboah J McClelland RL Polonsky TS Burke GL Sibley CT O’Leary D , et al.. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 2012; 308: 788–95.

Mohlenkamp S Lehmann N Breuckmann F Brocker-Preuss M Nassenstein K Halle M , et al.. Running: the risk of coronary events: prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J 2008; 29: 1903–10.

Schnohr P O’Keefe JH Marott JL Lange P Jensen GB . Dose of jogging and longterm mortality: the Copenhagen City Heart Study. J Am Coll Cardiol 2015; 65: 411–9.

Maron BJ Levine BD Washington RL Baggish AL Kovacs RJ Maron MS . Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 2: preparticipation screening for cardiovascular disease in competitive athletes: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015; 66: 2356–61.

Dvorak J Grimm K Schmied C Junge A . Development and implementation of a standardized precompetition medical assessment of international elite football players—2006 FIFA World Cup Germany. Clin J Sport Med 2009; 19: 316–21.

Ljungqvist A Jenoure P Engebretsen L Alonso JM Bahr R Clough A , et al.. The International Olympic Committee (IOC) Consensus Statement on periodic health evaluation of elite athletes March 2009. Br J Sports Med 2009; 43: 631–43.

Viskin S . Antagonist: routine screening of all athletes prior to participation in competitive sports should be mandatory to prevent sudden cardiac death. Heart Rhythm 2007; 4: 525–8.

Steinvil A Chundadze T Zeltser D Rogowski O Halkin A Galily Y , et al.. Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking? J Am Coll Cardiol 2011; 57: 1291–6.

Suissa S . Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 2008; 167: 492–9.

Roberts WO Maron BJ . Evidence for decreasing occurrence of sudden cardiac death associated with the marathon. J Am Coll Cardiol 2005; 46: 1373–4.

Maron BJ Haas TS Doerer JJ Thompson PD Hodges JS . Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am J Cardiol 2009; 104: 276–80.

Halkin A Steinvil A Rosso R Adler A Rozovski U Viskin S . Preventing sudden death of athletes with electrocardiographic screening: what is the absolute benefit and how much will it cost? J Am Coll Cardiol 2012; 60: 2271–6.

Fuller CM . Cost effectiveness analysis of screening of high school athletes for risk of sudden cardiac death. Med Sci Sports Exerc 2000; 32: 887–90.

Maron BJ Thompson PD Ackerman MJ Balady G Berger S Cohen D , et al.. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2007; 115: 1643–55.

Wheeler MT Heidenreich PA Froelicher VF Hlatky MA Ashley EA . Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes. Ann Intern Med 2010; 152: 276–86.

Leslie LK Cohen JT Newburger JW Alexander ME Wong JB Sherwin ED , et al.. Costs and benefits of targeted screening for causes of sudden cardiac death in children and adolescents. Circulation 2012; 125: 2621–9.

Schoenbaum M Denchev P Vitiello B Kaltman JR . Economic evaluation of strategies to reduce sudden cardiac death in young athletes. Pediatrics 2012; 130: e380–9.

Corrado D Basso C Thiene G . Pros and cons of screening for sudden cardiac death in sports. Heart 2013; 99: 1365–73.

Assanelli D Levaggi R Carre F Sharma S Deligiannis A Mellwig KP , et al.. Cost-effectiveness of pre-participation screening of athletes with ECG in Europe and Algeria. Intern Emerg Med 2015; 10: 143–50.

Van Camp SP Bloor CM Mueller FO Cantu RV Olson HG . Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc 1995; 27: 641–7.

Bohm P Scharhag J Meyer T . Data from a nationwide registry on sports-related sudden cardiac deaths in Germany. Eur J Prev Cardiol 2016; 23: 649–56.